Abstract
In this issue of Blood, Powell and colleagues present the first human data after the infusion of a new recombinant factor VIII (FVIII) product that when fused with the Fc fragment of IgG1 results in significantly prolonged half-life in the circulation.
Cite
CITATION STYLE
APA
Makris, M. (2012, March 29). Longer FVIII: The 4th generation. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-01-403675
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free